--- page 1 ---
1
Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited (the “Hong Kong Stock
Exchange ”) and Hong Kong Securities Clearing Company Limited ( “HKSCC ”) take no responsibility for the contents
of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability
whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this
announcement.
Unless otherwise defined herein, capitalized terms used in this announcement shall have the same meanings as those
defined in the prospectus dated June 30, 2025 (the “Prospectus ”) issued by Wuhan Dazhong Dental Medical Co., Ltd.
(ʮ̡ ) (the “Company ”).
This announcement is for information purposes only and does not constitute an invitation or offer to acquire, purchase
or subscribe for any securities of the Company. This announcement is not a prospectus. Potential investors should read
the Prospectus for detailed information about the Company and the Global Offering described below before deciding
whether or not to invest in the Offer Shares. Any investment decision in relation to the Offer Shares should be taken
solely in reliance on the information provided in the Prospectus.
This announcement is not for release, publication, distribution, directly or indirectly, in or into the United States
(including its territories and possessions, any state of the United States and the District of Columbia). This
announcement does not constitute or form a part of any offer or solicitation to purchase or subscribe for securities
in the United States or in any other jurisdiction. The Offer Shares have not been, and will not be, registered under
the United States Securities Act of 1933, as amended from time to time (the “U.S. Securities Act ”) or securities law
of any state or other jurisdiction of the United States and may not be offered, sold, pledged or otherwise transferred
within the United States, except in transactions exempt from, or not subject to, the registration requirements of the U.S.
Securities Act. The Company has not intended and does not intend to make any public offer of securities in the United
States. The Offer Shares are being offered and sold outside the United States in offshore transactions in reliance on
Regulation S under the U.S. Securities Act.
In connection with the Global Offering, Haitong International Securities Company Limited, as stabilizing manager (the
“Stabilizing Manager ”), its affiliates or any person acting for it, on behalf of the Underwriters, may over-allocate
or effect transactions with a view to stabilizing or supporting the market price of the H Shares at a level higher than
that which might otherwise prevail in an open market for a limited period after the Listing Date. However, there is no
obligation on the Stabilizing Manager, its affiliates or any person acting for it, to conduct any such stabilizing action,
which, if commenced, will be conducted at the sole and absolute discretion of the Stabilizing Manager, its affiliates or
any person acting for it, and may be discontinued at any time. Any such stabilizing activity is required to be brought
to an end on the 30th day after the last day for the lodging of applications under the Hong Kong Public Offering, being
August 3, 2025.
Such stabilization action, if commenced, may be effected in all jurisdictions where it is permissible to do so, in each
case in compliance with all applicable laws, rules and regulatory requirements, including the Securities and Futures
(Price Stabilizing) Rules (Cap. 571W of the Laws of Hong Kong), as amended, made under the Securities and Futures
Ordinance (Cap. 571 of the Laws of Hong Kong). Potential investors should be aware that stabilizing action cannot be
taken to support the price of the H Shares for longer than the stabilization period which will begin on the Listing Date
and is expected to expire on Sunday, August 3, 2025, being the 30th day after the last day for lodging applications
under the Hong Kong Public Offering. After this date, no further stabilizing action may be taken, and demand for the
H Shares, and therefore the price of the H Shares, could fall.
The Hong Kong Offer Shares will be offered to the public in Hong Kong subject to the terms and conditions set out in
the Prospectus. The Hong Kong Offer Shares will not be offered to any person who is outside Hong Kong and/or not
resident in Hong Kong. Potential investors of the Offer Shares should note that the Sole Sponsor and the Sole Overall
Coordinator (for itself and on behalf of the Hong Kong Underwriters) shall, in their sole and absolute discretion, be
entitled to terminate the Hong Kong Underwriting Agreement with immediate effect upon the occurrence of any of
the events set out in the section headed “Underwriting {  Underwriting Arrangements and Expenses {  Hong Kong
Public Offering {  Grounds for Termination ” in the Prospectus at any time prior to 8:00 a.m. (Hong Kong time) on the
Listing Date (which is currently expected to be on Wednesday, July 9, 2025).


--- page 2 ---
2
Wuhan Dazhong Dental Medical Co., Ltd.
ʮ̡
(A joint stock company with limited liability incorporated in the People ’s Republic of China)
Global Offering
Number of Offer Shares under the
Global Offering
: 10,861,800 H Shares
Number of Hong Kong Offer Shares : 1,949,500 H Shares (as adjusted after
 reallocation)
Number of International Offer Shares : 8,912,300 H Shares (as adjusted
 after reallocation)
Final Offer Price : HK$20.0 per H Share, plus brokerage of
 1.0%, SFC transaction levy of 0.0027%,
 AFRC transaction levy of 0.00015% and
 Hong Kong Stock Exchange trading fee of
 0.00565%
Nominal value : RMB1.00 per H Share
Stock Code : 2651
Sole Sponsor, Sole Overall Coordinator, Sole Global Coordinator,
Sole Bookrunner and Joint Lead Manager
Joint Lead Manager


--- page 3 ---
3

WUHAN DAZHONG DENTAL MEDICAL CO., LTD. / 武武漢漢大大眾眾口口腔腔醫醫療療股股份份有有限限公公司司
ANNOUNCEMENT OF FINAL OFFER PRICE AND
ALLOTMENT RESULTS
Unless otherwise defined herein, capitalised terms used in this announcement shall have the same meanings
as those defined in the prospectus dated June 30, 2025 (the “Prospectus”) issued by Wuhan Dazhong Dental
Medical Co., Ltd.(武漢大眾口腔醫療股份有限公司) (the “Company”).

Warning: In view of high concentration of shareholding in a small number of H Shareholders, H
Shareholders and prospective investors should be aware that the price of the H Shares could move
substantially even with a small number of H Shares traded and should exercise extreme caution when
dealing in the H Shares.
SUMMARY
Company information
Stock code  2651
Stock short name  DAZHONG DENTAL
Dealings commencement date  July 9, 2025*
*see note at the end of the announcement

Price Information
Final Offer Price  HK$20.0
Offer Price Range HK$20.0- HK$21.4

Offer Shares and Share Capital
Number of Offer Shares  10,861,800
Number of Offer Shares in Hong Kong Public Offering (as
adjusted after reallocation)
1,949,500
Number of Offer Shares in International Offering (as
adjusted after reallocation)
8,912,300
Number of issued Shares upon Listing  49,379,042

Over-allocation
No. of Offer Shares over-allocated  –
Note: There has been no over -allocation of International Offer Shares . Therefore, the Over -allotment
Option will not be exercised and will lapse upon Listing.

Proceeds
Gross proceeds (Note)  HK$217.24 million
Less: Estimated listing expenses payable based on Final
Offer Price
HK$(39.07) million
Net proceeds  HK$178.17 million

Note: Gross proceeds refers to the amount to which the issuer is entitled receive. For details of the use of
proceeds, please refer to the section headed “Future Plans and Use of Proceeds” of the Prospectus.


--- page 4 ---
4


ALLOTMENT RESULTS DETAILS
HONG KONG PUBLIC OFFERING

No. of valid applications  35,263
No. of successful applications  8,703
Subscription level  108.25 times
Reallocation  Yes
No. of Offer Shares initially available under the Hong Kong Public
Offering
1,086,200
No. of Offer Shares reallocated from the International Offering  863,300
Final no. of Offer Shares under the Hong Kong Public Offering (as
adjusted after reallocation)
1,949,500
% of Offer Shares under the Hong Kong Public Offering to the
Global Offering
approximately 18%

Note: For details of the final allocation of H Shares to the Hong Kong Public Offering, investors can refer to
https://www.hkeipo.hk/iporesult to perform a search by name or identification document number or
https://www.hkeipo.hk/iporesult  for the full list of allottees.
INTERNATIONAL OFFERING

No. of placees  112
Subscription Level  0.96 times
No. of Offer Shares initially available under the International
Offering
9,775,600
No. of Offer Shares reallocated to the Hong Kong Public Offering  863,300
Final no. of Offer Shares under the International Offer ing (as
adjusted after reallocation)
8,912,300
% of Offer Shares under the International Offer ing to the Global
Offering
approximately 82%

The Directors confirm that, to the best of their knowledge, information and belief, (i) none of the Offer Shares
subscribed by the placees and the public have been financed directly or indirectly by the Company, any of the
Directors, Supervisors, chief executive of the Company, controlling shareholders, substantial shareholders,
existing shareholders of the Company or any of its subsidiaries or their respective close associates ; and (ii)
none of the placees and the public who have purchased the Offer Shares are accustomed to taking instructions
from the Company, any of the Directors, Supervisors, chief executive of the Company, controlling shareholders,
substantial shareholders, existing shareholders of the Company or any of its subsidiaries or their respective
close associates in relation to the acquisition, disposal, voting or other disposition of  H Shares registered in
his/her/its name or otherwise held by him/her/it.


--- page 5 ---
5
LOCK-UP UNDERTAKINGS
Controlling Shareholders
Name
Number of
Shares held
in the
Company
subject to
lock-up
undertakings
  upon
Listing
Number of H
Shares held
in the
Company
subject to
lock-up
undertakings
upon Listing
% of H Shares
subject to
lockup
undertakings
as to total
issued H
Shares upon
Listing
% of Shares
subject to lock-
up
undertakings as
to total issued
Shares upon
Listing
Last day subject  to
the lock-up
undertakings (Note 1)
Hubei
Zhongshan
Medical
Investment
Management
Co., Ltd. (湖
北中山醫療投
資管理有限公
司)
31,324,102 0 0.00% 63.44% July 8, 2026
Mr. Yao Xue
(姚雪)
475,800 0 0.00% 0.96% July 8, 2026
Ms. Shen
Hongmin (沈
洪敏)
450,000 0 0.00% 0.91% July 8, 2026
Total 32,249,902 0 0.00% 65.31%
Note:
1. The  expiry date of the lock-up period shown in the table above is pursuant to the PRC Company Law.
In accordance with the relevant Listing Rules and guidance materials, the required lock -up for the
first six-month period ends on January 8, 2026 and for the second six-month period ends on July 8 ,
2026.


--- page 6 ---
6


Pre-IPO Investors
Name(Note 1)
Number of
Shares held in
the Company
subject to
lock-up
undertakings
upon Listing
Number of H
Shares held
in the
Company
subject to
lock-up
undertakings
upon Listing
% of H Shares
subject to
lockup
undertakings
as to total
issued H
Shares upon
Listing
% of Shares
subject to lock-
up
undertakings
as to total
issued Shares
upon Listing
Last day
subject  to the
lock-up
undertakings
(Note 2)
Ms. Li Zhen
(李臻)
206,800 206,800 1.21% 0.42% July 8, 2026
Mr. Chen Wei
(陳巍)
206,800 206,800 1.21% 0.42% July 8, 2026
Mr. Wang
Hong (王宏)
103,000 0 0.00% 0.21% July 8, 2026
Total 516,600 413,600 2.43% 1.05%

Notes:

1. Please refer to the section headed “History, Development and Corporate Structure — Pre-IPO
Investments —Information about the Pre-IPO Investors” in the Prospectus for details of the PreIPO
Investors.

2. The expiry day of the lock-up period shown in the table above is pursuant to the PRC Company Law.

Existing Shareholders (other than the Pre-IPO Investors as defined in the “History, Development and
Corporate Structure” section of the Prospectus)
Name
Number of
Shares held in
the Company
subject to
lock-up
undertakings
upon Listing
Number of H
Shares held
in the
Company
subject to
lock-up
undertakings
upon Listing
% of H Shares
subject to
lockup
undertakings
as to total
issued H
Shares upon
Listing
% of Shares
subject to lock-
up
undertakings
as to total
issued Shares
upon Listing
Last day
subject  to the
lock-up
undertakings
(Note 1)
Wuhan Xinglin
Management
Consulting
Partnership
(Limited
Partnership)( 武
漢杏林管理諮
詢合夥企業(有
限合夥))
2,740,740 2,740,740 16.10% 5.55% July 8, 2026
Wuhan Taolin
Management
1,505,000 1,505,000 8.84% 3.05% July 8, 2026


--- page 7 ---
7

Name
Number of
Shares held in
the Company
subject to
lock-up
undertakings
upon Listing
Number of H
Shares held
in the
Company
subject to
lock-up
undertakings
upon Listing
% of H Shares
subject to
lockup
undertakings
as to total
issued H
Shares upon
Listing
% of Shares
subject to lock-
up
undertakings
as to total
issued Shares
upon Listing
Last day
subject  to the
lock-up
undertakings
(Note 1)
Consulting
Partnership
(Limited
Partnership) (武
漢桃林管理諮
詢合夥企業(有
限合夥))
Wuhan Zhulin
Management
Consulting
Partnership
(Limited
Partnership)( 武
漢竹林管理諮
詢合夥企業(有
限合夥))
1,505,000 1,505,000 8.84% 3.05% July 8, 2026
Total 5,750,740 5,750,740 33.78% 11.65%

Note:

1. The expiry day of the lock-up period shown in the table above is pursuant to the PRC Company Law.


--- page 8 ---
8

PLACEE CONCENTRATION ANALYSIS

Placees(1)
Number of Shares
allotted(2)

Allotment as % of
International Offering
Allotment as % of total Offer
Shares
Number of
 Shares held upon Listing

% of total issued share capital
upon Listing
Top 1 3,500,000 39.27% 32.22% 3,500,000 7.09%
Top 5 8,900,000 99.86% 81.94% 8,900,000 18.02%
Top 10 8,901,800 99.88% 81.96% 8,901,800 18.03%
Top 25 8,903,600 99.90% 81.97% 8,903,600 18.03%

Notes:
1. Ranking of placees is based on the number of Shares allotted to the placees.

2. None of the Shares have been allocated to the Controlling Shareholders, Pre-IPO Investors or
the existing Shareholders.

H SHAREHOLDER CONCENTRATION ANALYSIS
Shareholders(1)
Number of H Shares
allotted(2)

Allotment as % of
International
Offering(3)
Allotment as % of total
Offer Shares
Number of H Shares
held upon Listing

% of total issued H
share capital upon
Listing
Number of Shares
held upon Listing
Top 1 3,500,000 39.27% 32.22% 3,500,000 20.56% 3,500,000
Top 5 5,000,000 56.10% 46.03% 10,750,740 63.14% 10,750,740
Top 10 8,900,000 99.86% 81.94% 15,064,340 88.48% 15,064,340
Top 25 9,181,000 99.86% 84.53% 15,345,340 90.13% 15,345,340

Notes:
1.  Ranking of H Shareholders is based on the number of H Shares  held by the H Shareholders
upon Listing.

2. None of the H Shares have been allocated to the Controlling Shareholders, Pre-IPO Investors
or the existing Shareholders.

3. Representing H Shares allotted to the top 25 H Shareholders (excluding the H Shares allotted
under the Hong Kong Public Offering), as a percentage of the International Offering.


--- page 9 ---
9

SHAREHOLDER CONCENTRATION ANALYSIS
Shareholders(1)
Number of H
Shares allotted(2)
Allotment as % of
International
Offering(3)
Allotment as %
of total Offer
Shares
Number of H Shares
held upon Listing
Number of Shares held
upon Listing
% of total issued
share capital upon
Listing
Top 1  -    0.00% 0.00%  -     32,249,902  65.31%
Top 5  3,500,000  39.27% 32.22%  9,250,740   41,500,642  84.05%
Top 10  8,900,000  99.86% 81.94%  14,857,540   47,107,442  95.40%
Top 25  9,146,500  99.86% 84.21%  15,310,840   47,663,742  96.53%

Notes:
1. Ranking of Shareholders is based on the number of Shares (of all classes) held by the
Shareholders upon Listing.

2. None of the H Shares have been allocated to the Controlling Shareholders, Pre-IPO Investors
or the existing Shareholders.

3. Representing H Shares allotted to the top 25 Shareholders (excluding the H Shares allotted
under the Hong Kong Public Offering), as a percentage of the International Offering.


BASIS OF ALLOCATION UNDER THE HONG KONG PUBLIC OFFERING
Subject to the satisfaction of the conditions set out in the Prospectus, a total of 35,263 valid
applications made by the public will be conditionally allocated on the basis set out below:
Number of H
Shares applied for
Number of valid
applications Basis of allocation/ballot
Approximate %
allotted of the total no.
of H Shares applied for
POOL A
100 13,328 1,333 out of 13,328 applicants to receive
100 H Shares
10.00%
200 2,848 400 out of 2,848 applicants to receive
100 H Shares
7.02%
300 7,799 1,334 out of 7,799 applicants to receive
100 H Shares
5.70%
400 824 163 out of 824 applicants to receive 100
H Shares
4.95%
500 1,389 305 out of 1,389 applicants to receive
100 H Shares
4.39%
600 317 77 out of 317 applicants to receive 100
H Shares
4.05%
700 217 57 out of 217 applicants to receive 100
H Shares
3.75%
800 186 52 out of 186 applicants to receive 100
H Shares
3.49%
900 176 52 out of 176 applicants to receive 100
H Shares
3.28%


--- page 10 ---
10

1,000 2,124 654 out of 2,124 applicants to receive
100 H Shares
3.08%
1,500 537 202 out of 537 applicants to receive 100
H Shares
2.51%
2,000 998 431 out of 998 applicants to receive 100
H Shares
2.16%
2,500 300 145 out of 300 applicants to receive 100
H Shares
1.93%
3,000 350 185 out of 350 applicants to receive 100
H Shares
1.76%
3,500 152 87 out of 152 applicants to receive 100
H Shares
1.64%
4,000 222 135 out of 222 applicants to receive 100
H Shares
1.52%
4,500 250 161 out of 250 applicants to receive 100
H Shares
1.43%
5,000 633 428 out of 633 applicants to receive 100
H Shares
1.35%
6,000 215 159 out of 215 applicants to receive 100
H Shares
1.23%
7,000 143 114 out of 143 applicants to receive 100
H Shares
1.14%
8,000 129 111 out of 129 applicants to receive 100
H Shares
1.08%
9,000 90 82 out of 90 applicants to receive 100 H
Shares
1.01%
10,000 735 100 H Shares 1.00%
20,000 397 100 H Shares plus 137 out of 397
applicants to receive an additional 100
H Shares
0.67%
30,000 220 100 H Shares plus 133 out of 220
applicants to receive an additional 100
H Shares
0.53%
40,000 109 100 H Shares plus 92 out of 109
applicants to receive an additional 100
H Shares
0.46%
50,000 168 200 H Shares 0.40%
60,000 63 200 H Shares plus 14 out of 63
applicants to receive an additional 100
H Shares
0.37%
70,000 28 200 H Shares plus 11 out of 28
applicants to receive an additional 100
H Shares
0.34%
80,000 34 200 H Shares plus 20 out of 34
applicants to receive an additional 100
H Shares
0.32%
90,000 21 200 H Shares plus 15 out of 21
applicants to receive an additional 100
H Shares
0.30%


--- page 11 ---
11

100,000 103 200 H Shares plus 83 out of 103
applicants to receive an additional 100
H Shares
0.28%
150,000 35 300 H Shares plus 16 out of 35
applicants to receive an additional 100
H Shares
0.23%
200,000 40 400 H Shares 0.20%

Total   35,180 Total number of Pool A successful applicants: 8,620
POOL B
 250,000   51  9,300 H Shares 3.72%
 300,000   7  11,000 H Shares 3.67%
 350,000   4  12,800 H Shares 3.66%
 400,000   4  14,600 H Shares 3.65%
 450,000   3  16,400 H Shares 3.64%
 500,000   6  18,100 H Shares 3.62%
 543,100   8  19,500 H Shares 3.59%

Total 83 Total number of Pool B successful applicants: 83

As of the date of this announcement, the relevant subscription monies previously deposited in the
designated nominee accounts have been remitted back to the accounts of all HKSCC participants .
Investors  should contact their relevant brokers for any inquiries.

COMPLIANCE WITH LISTING RULES AND GUIDANCE
The Directors confirm that the Company has complied with the Listing Rules and guidance materials
in relation to the placing, allotment and listing of the Company’s H Shares.
The Directors confirm that, to the best of their knowledge, no rebate has been, directly or indirectly,
provided by the Company, Directors or syndicate members to any places or the public (as the case may
be) and the consideration paid by them for each Offer Share subscribed for or purchased by them was
the same as the final Offer Price in addition to any brokerage, AFRC transaction levy, SFC transaction
levy and trading fee payable.
OTHERS/ADDITIONAL INFORMATION
Reallocation

As the Hong Kong Offer Shares initially offered under the Hong Kong Public Offering have been
oversubscribed by more than 100 times of the total number of Offer Shares initially available under
the Hong Kong Public Offering, the reallocation procedure as disclosed in the section headed
“Structure of the Global Offering – The Hong Kong Public Offering – Reallocation” of the Prospectus
has been applied. However, since the International Offer Shares initially offered under the International
Offering have been undersubscribed, the reallocation of 4,344,700 Offer Shares from the International
Offering to the Hong Kong Public Offering as disclosed in the section headed “Structure of the Global
Offering – The Hong Kong Public Offering – Reallocation” of the Prospectus has not been triggered.


--- page 12 ---
12

As a result of such reallocation, the final number of Offer Shares under the Hong Kong Public Offering
is adjusted to 1,949,500 Shares, representing approximately 18% of the total number of Offer Shares
initially available under the Global Offering, and the final number of Offer Shares under the
International Offering is adjusted to 8,912,300 Shares, representing approximately 82% of the total
number of Offer Shares initially available under the Global Offering.

DISCLAIMERS

Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited and Hong
Kong Securities Clearing Company Limited  take no responsibility for the contents of this
announcement, make no representation as to its accuracy or completeness and expressly disclaim
any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any
part of the contents of this announcement.
This announcement is not for release, publication, distribution, directly or indirectly, in or into the
United States (including its territories and possessions, any state of the United States and the District
of Columbia). This announcement does not constitute  or form a part of any offer or solicitation to
purchase or subscribe for securities in   the United States. The securities mentioned herein have not
been, and will not be, registered under the United States Securities Act of 1933, as amended (the “ U.S.
Securities Act ”). The securities may not be offered or sold in the United States except pursuant to an
exemption from the registration requirements of the U.S. Securities Act and in compliance with any
applicable state securities laws, or outside the United States unless in compliance with Regulation S
under the U.S. Securities Act. There will be no public offer of securities in the United States.
The Offer Shares are being offered and sold outside the United States in offshore transactions in reliance
on Regulation S under the U.S. Securities Act.
This announcement is for information purposes only and does not constitute an invitation or offer to
acquire, purchase or subscribe for securities. This announcement is not a prospectus. Potential
investors should read the Prospectus dated June 30, 2025 issued by Wuhan Dazhong Dental Medical
Co., Ltd. ( 武漢大眾口腔醫療股份有限公司 ) for detailed information about the Global Offering
described below before deciding whether or not to invest in the H Shares thereby being offered.
*Potential investors of  the Offer Shares should note that the Sole Overall Coordinator  (for itself and
on behalf of  the Hong Kong Underwriters) shall be entitled to terminate their obligations under the
Hong Kong Underwriting Agreement with immediate effect upon the occurrence of any of the events
set out in the paragraph headed “Underwriting – Underwriting Arrangements and Expenses – Hong
Kong Public Offering – Hong Kong Underwriting Agreement – Grounds for Termination ” in the
Prospectus at any time prior to  8:00 a.m. (Hong Kong time) on  the  Listing  Date (which is currently
expected  to be on July 9, 2025).


--- page 13 ---
13
PUBLIC FLOAT
Immediately after the completion of the Global Offering, 15,521,140 H Shares, representing
approximately 31.43% of the total issued share capital of the Company will count towards the
public float, satisfying the minimum percentage prescribed by Rule 8.08 of the Listing Rules.
The Directors confirm that, immediately following completion of the Global Offering: (i) the H
Shares will be held by at least 300 Shareholders at the time of Listing, in compliance with Rule
8.08(2) of the Listing Rules; (ii) the three largest public Shareholders will not hold more than 50%
of the Shares held in public hands at the time of Listing, in compliance with Rule 8.08(3) of the
Listing Rules; (iii) no placee will, individually, be placed more than 10% of the enlarged issued
share capital of the Company immediately after the Global Offering; and (iv) there will not be
any new substantial Shareholder (as defined in the Listing Rules) immediately after the Global
Offering.
COMMENCEMENT OF DEALINGS
The H Share certificates will only become valid evidence of title at 8:00 a.m. on Wednesday, July
9, 2025 (Hong Kong time), provided that the Global Offering has become unconditional and the
right of termination described in the section headed “Underwriting ” in the Prospectus has not been
exercised. Investors who trade the H Shares on the basis of publicly available allocation details
prior to the receipt of H Share certificates or prior to the H Share certificates becoming valid
evidence of title do so entirely at their own risk.
Assuming that the Global Offering becomes unconditional at or before 8:00 a.m. on Wednesday,
July 9, 2025 (Hong Kong time), it is expected that dealings in the H Shares on the Stock Exchange
will commence at 9:00 a.m. on Wednesday, July 9, 2025 (Hong Kong time). The H Shares will be
traded in board lots of 100 H Shares each, and the stock code of the H Shares will be 2651.
By order of the Board
Wuhan Dazhong Dental Medical Co., Ltd.
ʮ̡
Mr. Yao Xue
Chairman and Executive Director
Hong Kong, July 8, 2025
As at the date of this announcement, the board of directors of the Company comprises (i) Mr. Yao
Xue, Ms. Shen Hongmin, Mr. Guo Jiaping and Ms. Liu Hongchan as executive directors; and (ii)
Mr. Shu Yijie, Ms. Huang Suzhen and Ms. Wang Taosha as independent non-executive directors,
effective upon Listing.
